{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:50Z","timestamp":1786119290132,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/mph.0b013e31819d9119","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T09:38:33Z","timestamp":1242898713000},"page":"277-280","source":"Crossref","is-referenced-by-count":3,"title":["A Novel Type 2A von Willebrand Factor Mutation (V1499E) Associated With Variable Clinical Expression"],"prefix":"10.1097","volume":"31","author":[{"given":"Esther","family":"van den Heuvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel M.","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Schneppenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"van Mourik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florens G. A.","family":"Versteegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210227","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R2-9-20210227","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2005-04-1758","article-title":"Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis","volume":"107","author":"Hassenpflug","year":"2006","journal-title":"Blood"},{"key":"R3-9-20210227","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"key":"R4-9-20210227","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"R5-9-20210227","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2002-27814","article-title":"Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications","volume":"28","author":"Michiels","year":"2002","journal-title":"Sem Thromb Hemostas"},{"key":"R6-9-20210227","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00894-004-0194-9","article-title":"Molecular modeling of the von Willebrand factor A2 domain and the effects of associated type 2A von Willebrand disease mutations","volume":"10","author":"Sutherland","year":"2004","journal-title":"J Mol Model"},{"key":"R7-9-20210227","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1538-7836.2005.01571.x","article-title":"Cysteine-mutations in von Willebrand factor associated with increased clearance","volume":"3","author":"Schooten","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R8-9-20210227","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"R9-9-20210227","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood.V91.6.2032","article-title":"Molecular modelling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease","volume":"91","author":"Jenkins","year":"1998","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e31819d9119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:25Z","timestamp":1786038625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200904000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31819d9119","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}